Clinical Trial: Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome(R) Post LB on IBS Gastrointestinal Symptoms

U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06889779) titled 'Study Evaluating the Efficacy of Different Mixes of HMO-2FL + Humiome(R) Post LB on IBS Gastrointestinal Symptoms' on Feb. 20.

Brief Summary: A randomized, placebo-controlled, double-blind clinical study to evaluate the efficacy of two different mixes of HMO-2'-O-fucosyllactose (HMO-2FL) + Humiome(R) Post LB postbiotic (postbiotic-LB) on Gastrointestinal Symptoms in individuals with Irritable Bowel Syndrome (IBS)

Study Start Date: April 15

Study Type: INTERVENTIONAL

Condition: IBS (Irritable Bowel Syndrome)

Intervention: DIETARY_SUPPLEMENT: MIX 1

Humiome(R) Post LB postbiotic 300 mg , Human Milk Oligosaccharides 2'-Ofucosyll...